Invention Grant
US09096600B2 N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
有权
N-（1-（取代苯基）乙基）-9H-嘌呤-6-胺作为PI3K抑制剂
- Patent Title: N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
- Patent Title (中): N-（1-（取代苯基）乙基）-9H-嘌呤-6-胺作为PI3K抑制剂
-
Application No.: US13329532Application Date: 2011-12-19
-
Publication No.: US09096600B2Publication Date: 2015-08-04
- Inventor: Yun-Long Li , Andrew P. Combs , Eddy W. Yue , Thomas P. Maduskuie, Jr. , Richard B. Sparks
- Applicant: Yun-Long Li , Andrew P. Combs , Eddy W. Yue , Thomas P. Maduskuie, Jr. , Richard B. Sparks
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D473/34
- IPC: C07D473/34 ; C07D473/32
Abstract:
The present invention provides N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines derivatives that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
Public/Granted literature
- US20120157430A1 N-(1-(SUBSTITUTED-PHENYL)ETHYL)-9H-PURIN-6-AMINES AS PI3K INHIBITORS Public/Granted day:2012-06-21
Information query
